Claudia Giannotta

969 total citations
20 papers, 467 citations indexed

About

Claudia Giannotta is a scholar working on Neurology, Cellular and Molecular Neuroscience and Immunology. According to data from OpenAlex, Claudia Giannotta has authored 20 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 10 papers in Cellular and Molecular Neuroscience and 5 papers in Immunology. Recurrent topics in Claudia Giannotta's work include Peripheral Neuropathies and Disorders (14 papers), Hereditary Neurological Disorders (9 papers) and Multiple Myeloma Research and Treatments (4 papers). Claudia Giannotta is often cited by papers focused on Peripheral Neuropathies and Disorders (14 papers), Hereditary Neurological Disorders (9 papers) and Multiple Myeloma Research and Treatments (4 papers). Claudia Giannotta collaborates with scholars based in Italy, France and Slovakia. Claudia Giannotta's co-authors include Eduardo Nobile‐Orazio, Francesca Gallia, Fabrizia Terenghi, Sandro Sonnino, Vanna Chigorno, Alessandro Prinetti, Chiara Briani, Andrea Nozza, Massimo Massaia and S. Allaria and has published in prestigious journals such as Journal of Biological Chemistry, Neurology and Journal of Lipid Research.

In The Last Decade

Claudia Giannotta

19 papers receiving 448 citations

Peers

Claudia Giannotta
Comparison fields: 5 of 54
  • Neurology 311
  • Cellular and Molecular Neuroscience 189
  • Molecular Biology 134
  • Radiology, Nuclear Medicine and Imaging 63
  • Physiology 55
S. Allaria Italy
Nobuyuki Miyatani Japan
Rosaria Leante Italy
Wendy K. Roberts United States
Astrid Nümann Germany
Clemens Stockklausner Germany
Amandip S. Gill United States
Céline Labeyrie France
Akatsuki Kubota Japan
Giuseppe Liberatore Italy
S. Allaria Italy View profile →
Citations per field, relative to Claudia Giannotta
Claudia Giannotta · 1×
Citations per year, relative to Claudia Giannotta
Claudia Giannotta · 1×

Countries citing papers authored by Claudia Giannotta

Since Specialization
Citations

This map shows the geographic impact of Claudia Giannotta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Giannotta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Giannotta more than expected).

Fields of papers citing papers by Claudia Giannotta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Giannotta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Giannotta. The network helps show where Claudia Giannotta may publish in the future.

Co-authorship network of co-authors of Claudia Giannotta

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Giannotta. A scholar is included among the top collaborators of Claudia Giannotta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Giannotta. Claudia Giannotta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies Journal of Neurology Neurosurgery & Psychiatry Pietro Emiliano Doneddu, Dario Cocito et al. 9
2 Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma Blood Cancer Journal Bachisio Ziccheddu, Claudia Giannotta et al. 4
3 Regular assessment of serum vascular endothelial growth factor levels to monitor POEMS syndrome Neurological Sciences Francesco Gentile, Fabrizia Terenghi et al. 0
4 The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells Frontiers in Immunology Claudia Giannotta, Massimo Massaia et al. 20
5 Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time? Frontiers in Immunology Claudia Giannotta, Massimo Massaia et al. 7
6 Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status Frontiers in Immunology Claudia Giannotta, Barbara Castella et al. 4
7 A diagnostic score for anti‐myelin‐associated‐glycoprotein neuropathy or chronic inflammatory demyelinating polyradiculoneuropathy in patients with anti‐myelin‐associated‐glycoprotein antibody European Journal of Neurology Pietro Emiliano Doneddu, Marta Ruiz et al. 10
8 Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy Journal of Neuroimmunology Giuseppe Liberatore, Claudia Giannotta et al. 23
9 Clinical, electrophysiological and VEGF 2-year response after lenalidomide or stem cell transplantation in patients with POEMS syndrome Journal of Neurology Neurosurgery & Psychiatry Mariangela Bianco, Fabrizia Terenghi et al. 4
10 Anti-ganglioside antibodies: experience from the Italian Association of Neuroimmunology external quality assessment scheme Clinical Chemistry and Laboratory Medicine (CCLM) Diego Franciotta, Matteo Gastaldi et al. 8
11 Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens Neurological Sciences Luigi Zuliani, Marco Zoccarato et al. 15
12 Anti‐sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies European Journal of Neurology Susanna Ruggero, Claudia Giannotta et al. 9
13 Anti‐sulfatide IgM antibodies in peripheral neuropathy: to test or not to test? European Journal of Neurology Claudia Giannotta, Francesca Gallia et al. 18
14 Sensitivity and predictive value of anti-GM1/galactocerebroside IgM antibodies in multifocal motor neuropathy Journal of Neurology Neurosurgery & Psychiatry Eduardo Nobile‐Orazio, Claudia Giannotta et al. 54
15 Testing for anti‐glycolipid IgM antibodies in chronic immune‐mediated demyelinating neuropathies Journal of the Peripheral Nervous System Eduardo Nobile‐Orazio, Claudia Giannotta 7
16 Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies Journal of Neuroimmunology Eduardo Nobile‐Orazio, Claudia Giannotta et al. 42
17 SERUM VEGF LEVELS IN POEMS SYNDROME AND IN IMMUNE-MEDIATED NEUROPATHIES Neurology Eduardo Nobile‐Orazio, Fabrizia Terenghi et al. 68
18 How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies? Journal of the Neurological Sciences Eduardo Nobile‐Orazio, Francesca Gallia et al. 60
19 Sphingolipid Uptake by Cultured Cells Journal of Biological Chemistry Vanna Chigorno, Claudia Giannotta et al. 38
20 Dynamics of membrane lipid domains in neuronal cells differentiated in culture Journal of Lipid Research Alessandro Prinetti, Simona Prioni et al. 67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026